BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2776253)

  • 61. [Accuracy of frozen section in diagnosis of ovarian tumors].
    Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 1993 Oct; 28(10):601-3, 635. PubMed ID: 8112130
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pancreatic cystadenoma and cystadenocarcinoma: diagnostic value of preoperative morphological investigations.
    de Calan L; Levard H; Hennet H; Fingerhut A
    Eur J Surg; 1995 Jan; 161(1):35-40. PubMed ID: 7727604
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [A case of liver cystadenoma--significance of tumor marker level of the cyst fluid in differentiating pathological nature].
    Kitao Y; Seki T; Kubota Y; Nonaka T; Tateiwa J; Mizuno T; Shiozaki Y; Sameshima Y
    Nihon Shokakibyo Gakkai Zasshi; 1990 Apr; 87(4):1078-82. PubMed ID: 2198360
    [No Abstract]   [Full Text] [Related]  

  • 64. An enzyme-linked lectin assay for the study of lectin receptors of Leishmania.
    Andrade PP; Schottelius J; Andrade CR
    Braz J Med Biol Res; 1988; 21(3):517-21. PubMed ID: 3228632
    [TBL] [Abstract][Full Text] [Related]  

  • 65. LH(hCG) receptor in benign and malignant tumors of human ovary.
    Rajaniemi H; Kauppila A; Rönnberg L; Selander K; Pystynen P
    Acta Obstet Gynecol Scand Suppl; 1981; 101():83-6. PubMed ID: 6272525
    [TBL] [Abstract][Full Text] [Related]  

  • 66. C-myc oncogene product P62c-myc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy.
    Polacarz SV; Hey NA; Stephenson TJ; Hill AS
    J Clin Pathol; 1989 Feb; 42(2):148-52. PubMed ID: 2921356
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [CYTOLOGIC EXAMINATION OF ASCITIC FLUID AS A METHOD FOR THE DETECTION OF OVARIAN TUMORS].
    KLIMANOVA ZF
    Akush Ginekol (Mosk); 1964; 40():55-61. PubMed ID: 14248258
    [No Abstract]   [Full Text] [Related]  

  • 68. [Correlation between estrogen and progestin receptor protein and histopathology in ovarian tumor].
    Wang JH; Han SW; Cao ZY; Wang SL; Sun WG
    Hua Xi Yi Ke Da Xue Xue Bao; 1988 Sep; 19(3):301-4. PubMed ID: 3253178
    [No Abstract]   [Full Text] [Related]  

  • 69. Papillary serous cystadenoma of the testis.
    Kosmehl H; Langbein L; Kiss F
    Int Urol Nephrol; 1989; 21(2):169-74. PubMed ID: 2473043
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pregnancies following conservative treatment of malignant ovarian tumors.
    Shiromizu K; Kawana T; Sugase M; Takizawa K; Kawagoe K; Izumi R; Mizuno M
    Arch Gynecol Obstet; 1987; 241(1):57-62. PubMed ID: 3674984
    [TBL] [Abstract][Full Text] [Related]  

  • 71. STUDIES ON CANCER OF THE OVARY IN FINLAND, 1953-1956.
    UNNERUS CE
    Natl Cancer Inst Monogr; 1964 Oct; 15():149-54. PubMed ID: 14248005
    [No Abstract]   [Full Text] [Related]  

  • 72. Papillary serous tumors of the ovary: an electron microscopic study.
    Blaustein A
    Gynecol Oncol; 1976 Sep; 4(3):314-23. PubMed ID: 964700
    [No Abstract]   [Full Text] [Related]  

  • 73. Ovarian masses: changing clinico histopathological trends.
    Sharadha S; Sridevi TA; Renukadevi TK; Gowri R; Binayak D; Indra V
    J Obstet Gynaecol India; 2015 Feb; 65(1):34-8. PubMed ID: 25737620
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Studies on cytology and cytochemistry of cilioepithelial tumor cells in puncture of serous ovarian cystomas and cystadenocarcinomas].
    EBNER HJ
    Z Krebsforsch; 1953; 59(5):581-93. PubMed ID: 13170386
    [No Abstract]   [Full Text] [Related]  

  • 75. Ultrastructure of ovarian tumors. I. Papillary serous cystadenocarcinoma.
    Roberts DK; Marshall RB; Wharton JT
    Cancer; 1970 Apr; 25(4):947-58. PubMed ID: 4910128
    [No Abstract]   [Full Text] [Related]  

  • 76. Differential diagnosis of ovarian benign and malignant tumors by CT.
    Rohde U; Steinbrich W
    J Belge Radiol; 1983; 66(1):9-14. PubMed ID: 6619093
    [No Abstract]   [Full Text] [Related]  

  • 77. Relationship between RANTES and dendritic cells in ovarian cancer patients.
    Wertel I; Tarkowski R; Bednarek W; Kotarski J
    Front Biosci (Elite Ed); 2011 Jan; 3(1):227-32. PubMed ID: 21196302
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Papillary cystadenocarcinoma of the ovary.
    CROMER JK
    Med Ann Dist Columbia; 1946 Sep; 15():425-8. PubMed ID: 20997269
    [No Abstract]   [Full Text] [Related]  

  • 79. Response on: reduced expression of NDUFS3 and its clinical significance in serous ovarian cancer.
    Piek JM
    Int J Gynecol Cancer; 2013 Oct; 23(8):1348. PubMed ID: 24257547
    [No Abstract]   [Full Text] [Related]  

  • 80. [A CASE OF CARCINOMATOUS CYSTOADENOMA OF THE OVARY ASSOCIATED WITH A SPECIFIC SUBACUTE EXUDATIVE-EXFOLIATIVE INFLAMMATION OF SEROUS MEMBRANES, PROBABLY OF TUBERCULOUS ORIGIN].
    KOZACZENKO J; KUCZYNSKI F
    Ginekol Pol; 1964; 35():603-8. PubMed ID: 14275090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.